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P4-ATPases comprise a family of P-type ATPases that actively transport or flip
phospholipids across cell membranes. This generates and maintains membrane lipid
asymmetry, a property essential for a wide variety of cellular processes such as vesicle
budding and trafficking, cell signaling, blood coagulation, apoptosis, bile and cholesterol
homeostasis, and neuronal cell survival. Some P4-ATPases transport phosphatidylserine
and phosphatidylethanolamine across the plasma membrane or intracellular membranes
whereas other P4-ATPases are specific for phosphatidylcholine. The importance of
P4-ATPases is highlighted by the finding that genetic defects in two P4-ATPases ATP8A2
and ATP8B1 are associated with severe human disorders. Recent studies have provided
insight into how P4-ATPases translocate phospholipids across membranes. P4-ATPases
form a phosphorylated intermediate at the aspartate of the P-type ATPase signature
sequence, and dephosphorylation is activated by the lipid substrate being flipped from
the exoplasmic to the cytoplasmic leaflet similar to the activation of dephosphorylation
of Na+/K+-ATPase by exoplasmic K+. How the phospholipid is translocated can be
understood in terms of a peripheral hydrophobic gate pathway between transmembrane
helices M1, M3, M4, and M6. This pathway, which partially overlaps with the suggested
pathway for migration of Ca2+ in the opposite direction in the Ca2+-ATPase, is wider
than the latter, thereby accommodating the phospholipid head group. The head group
is propelled along against its concentration gradient with the hydrocarbon chains
projecting out into the lipid phase by movement of an isoleucine located at the position
corresponding to an ion binding glutamate in the Ca2+- and Na+/K+-ATPases. Hence,
the P4-ATPase mechanism is quite similar to the mechanism of these ion pumps,
where the glutamate translocates the ions by moving like a pump rod. The accessory
subunit CDC50 may be located in close association with the exoplasmic entrance of
the suggested pathway, and possibly promotes the binding of the lipid substrate. This
review focuses on properties of mammalian and yeast P4-ATPases for which most
mechanistic insight is available. However, the structure, function and enigmas associated
with mammalian and yeast P4-ATPases most likely extend to P4-ATPases of plants and
other organisms.
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INTRODUCTION
Non-random distribution of lipids across the lipid bilayer is
a characteristic feature of most eukaryotic cell membranes.
This asymmetrical distribution is most evident in the plasma
membrane where phosphatidylcholine (PC), sphingomyelin,
and glycolipids are enriched on the external or exoplasmic
leaflet of the membranes and phosphatidylserine (PS),
phosphatidylethanolamine (PE), and phosphatidylinositol
(PI) are primarily confined to the cytoplasmic leaflet (Zachowski,
1993; Lenoir et al., 2007). Cholesterol, a major lipid of the plasma
membrane, can move freely between the two leaflets, but is likely
to be more concentrated on the exoplasmic leaflet due to its
affinity for sphingomyelin and glycosphingolipids. Membranes
of other subcellular organelles including the trans-Golgi network
(TGN), secretory vesicles, and endosomes show a similar
asymmetrical distribution of lipids. Membrane lipid asymmetry
plays a crucial role in numerous cellular processes that take
place at the plasma membrane and intracellular membranes
including cell and organelle shape determination and dynamics,
vesicle budding and trafficking, membrane protein regulation,
membrane stability and impermeability, cell signaling, neurite
extension, blood coagulation, apoptosis, fertilization, and bile
and cholesterol homeostasis, among others.
The amphipathic nature of phospholipids impedes their
transverse movement or flip-flop across the hydrophobic
lipid bilayer. The half time for phospholipid flip-flop in
protein-free liposomes typically exceeds several hours. However,
the movement of lipids across biological membranes is
greatly accelerated by membrane proteins generally called
flippases (Pomorski and Menon, 2006). Three families of
proteins, scramblases, ATP-binding cassette (ABC) transporters,
and P4-ATPases, have been implicated in the transverse
movement of lipids across membranes. Scramblases are energy-
independent, bidirectional transporters that dissipate membrane
asymmetry (Williamson, 2015). Ca2+-activated scramblases play
an important role in exposing PS on the surface of cells
to initiate such cellular processes as blood coagulation and
apoptosis. Some scramblases such as the G-protein coupled
receptor rhodopsin are constitutively active thereby randomizing
transmembrane lipid distribution in specialized membranes such
as photoreceptor discs (Menon et al., 2011). ABC transporters
and P4-ATPases use the energy from ATP hydrolysis to transport
specific lipids across membranes against their concentration
gradient, thereby establishing and maintaining lipid asymmetry
in biological membranes (Coleman et al., 2013; Lopez-Marques
et al., 2014). Most ABC transporters translocate lipids from the
cytoplasmic to the exoplasmic leaflet of membranes and are often
called floppases. Some mammalian ABC transporters, however,
can transport phospholipids in the opposite direction (Quazi and
Molday, 2013). P4-ATPases are a subfamily of P-type ATPases
that transport specific phospholipids from the exoplasmic to
the cytoplasmic leaflet of membranes to generate and maintain
membrane lipid asymmetry (Tang et al., 1996; Coleman et al.,
2009; Zhou and Graham, 2009).
A number of excellent reviews have focused on the molecular
properties of lipid flippases and their role in cellular processes
(Sebastian et al., 2012; Coleman et al., 2013; Lopez-Marques et al.,
2013, 2014; Hankins et al., 2015; Williamson, 2015; Montigny
et al., 2016). In this review we discuss recent studies on the lipid
substrate specificity and transport mechanism of P4-ATPases
and their role in cell physiology and disease with emphasis on
mammalian and yeast P4-ATPases. We also present an overview
of recent site-directed mutagenesis and molecular modeling
studies that provide insight into the possible pathways used
by P4-ATPases to translocate phospholipids across membranes.
Finally, we discuss similarities in the structure and transport
mechanisms of P4-ATPase lipid pumps and P2-ATPase ion
pumps.
P-TYPE-ATPases
P-type ATPases constitute a family of membrane proteins that
utilize the energy from ATP hydrolysis to transport ions and
lipids across biological membranes (Palmgren and Nissen, 2011).
These pumps are found in prokaryotes, archaea, and eukaryotes
and are distinguished from other ATP-dependent transporters by
the presence of a conserved aspartic acid residue that undergoes
transient phosphorylation during the ATP cycle (Pedersen and
Carafoli, 1987). On the basis of phylogenetic analysis, P-type
ATPases have been organized into five main classes (P1-P5
ATPases) (Palmgren and Axelsen, 1998). The first three classes
have been further divided into subclasses based on sequence
similarity and ion transport specificity. P1A-ATPases are only
found in some bacteria and transport K+; P1B-ATPases transport
heavy metal ions such as Ag+, Zn2+, Cd2+, and Cu2+; P2A
ATPases (sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)
and secretory pathway Ca2+-ATPase (SPCA)) and P2B ATPases
(plasma membrane Ca2+-ATPase (PMCA)) transport Ca2+ and
Mn2+; P2C-ATPases transport monovalent ions and include
Na+/K+-ATPases and H+/K+-ATPases; P2D-ATPases are found
in fungi and transport Na+; P3A-ATPases transport H+; and P3B
ATPases transport Mg2+. P4-ATPases are unique in that they
transport or flip phospholipids across membranes. The substrates
for P5-ATPases have yet to be determined, but they are predicted
to play an important role in the endosomal-lysosomal system
and have been implicated in Parkinson’s disease (Schultheis et al.,
2004; Cohen et al., 2013; De La Hera et al., 2013).
P4-ATPases
P4-ATPases are only found in eukaryotes. The human genome
encodes 14 P4-ATPases that are organized into five classes with
each class having multiple members (Table 1, Figure 1A): Class
1a (ATP8A1, ATP8A2); Class 1b (ATP8B1, ATP8B2, ATP8B3,
ATP8B4); Class 2 (ATP9A, ATP9B); Class 5 (ATP10A, ATP10B,
ATP10D); and Class 6 (ATP11A, ATP11B, ATP11C) (Paulusma
and Elferink, 2010; Van Der Mark et al., 2013). In contrast, yeast
(Saccharomyces cerevisiae) contains five P4-ATPases (Drs2p,
Neo1p, Dnf1p, Dnf2p, Dnf3P).
All P4-ATPases consist of a large polypeptide with a molecular
mass of approximately 120 kDa which is composed of four
main domains (Figure 1B). Based on amino acid sequence
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TABLE 1 | Mammalian P4-ATPases.
Class P4-ATPase Complex
(α/β)
Substrate Expression Disease/Disorder References
Class 1a ATP8A1/CDC50A PS >PE Ubiquitous, high in skeletal
muscle, thyroid, spinal cord
Defective
hippocampus-dependent
learning (mice)
Levano et al., 2012; Kato et al.,
2013; Lee et al., 2015
ATP8A2/CDC50A PS > PE High in brain, retina, testis,
spinal cord
Cerebellar Ataxia, Mental
Retardation and
Disequilibrium Syndrome
(CAMRQ) (humans)
Neurological degeneration,
spinal, axonal degeneration;
retinal degeneration; hearing
loss (mice)
Coleman et al., 2009, 2014;
Onat et al., 2012; Zhu et al.,
2012; Vestergaard et al., 2014
Class 1b ATP8B1/CDC50A
ATP8B1/CDC50B
PC (PS?) Ubiquitous, high in small
intestine, pancreas
Progressive Familial
Intrahepatic Cholestasis
(PFIC); Benign Recurrent
Intrahepatic Cholestasis
(BRIC) (human) Intrahepatic
cholestasis, hearing loss,
(mice)
Bull et al., 1998; Eppens et al.,
2001; Paulusma et al., 2006;
Stapelbroek et al., 2009; Folmer
et al., 2009b; Takatsu et al., 2014
ATP8B2/CDC50A
ATP8B2/CDC50B
PC Ubiquitous Unknown Takatsu et al., 2014
ATP8B3/?? PS? Testis Abnormal sperm-egg
interactions
Wang et al., 2004; Gong et al.,
2009
ATP8B4/CDC50A
ATP8B4/CDC50B?
Unknown Moderate levels throughout
brain
Alzheimer disease? Li et al., 2008; Van Der Velden
et al., 2010b
ATP8B5 (FetA) Unknown Testis Defects in sperm
capacitation
Xu et al., 2009
Class 2 ATP9A Unknown Ubiquitous, high in brain,
pancreas
Unknown Takatsu et al., 2011; Ansari et al.,
2015
ATP9B Unknown Ubiquitous, high in testis Unknown Takatsu et al., 2011
Class 5 ATP10A/CDC50A PC High in brain, pancreas,
kidney, lung
Obesity, type 2 diabetes,
insulin resistance
Dhar et al., 2004, 2006; Naito
et al., 2015
ATP10B/CDC50A Unknown Low expression, brain Unknown
ATP10D/CDC50A Unknown High in placenta, low kidney,
undetectable in other major
organs
Obesity; hyperinsulinemia Flamant et al., 2003; Takatsu
et al., 2011
Class 6 ATP11A/CDC50A PS > PE Ubiquitous, moderate levels
in liver, skeletal muscle,
ovary
Marker for metastasis in
colorectal cancer (human)
Miyoshi et al., 2010; Takatsu
et al., 2014
ATP11B/CDC50A PS > PE Ubiquitous, high levels in
kidney, testis, ovary
Unknown
ATP11C/CDC50A PS > PE Ubiquitous, high liver,
pancreas, heart
Impaired B lymphocyte
differentiation, cholestasis,
hepatocarcinoma; anemia,
altered erythrocyte shape
(mice)
Siggs et al., 2011b;Takatsu
et al., 2014; Yabas et al., 2014
alignment (Figure 2), P4-ATPases possess three cytoplasmic
domains involved in the ATPase catalytic cycle similar to
Ca2+-ATPase and Na+,K+-ATPase: the nucleotide or N-domain
binds ATP; the phosphorylation or P-domain contains the
aspartic acid (D) residue within the conserved DKTGT motif
that undergoes transient phosphorylation; and the actuator
or A-domain has the DGET (TGES in Ca2+-ATPase and
Na+/K+-ATPase) motif that facilitates the dephosphorylation of
the phosphorylated intermediate (Lenoir et al., 2009; Coleman
et al., 2012). The membrane or M-domain serves as the pathway
for translocation of lipid substrates across cell membranes and
is predicted to contain 10 transmembrane segments (M1-M10,
Figure 2) analogous to the Ca2+-ATPase and the Na+/K+-
ATPase (Maclennan et al., 1985; Toyoshima et al., 2000; Morth
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et al., 2007). Relatively short segments join the transmembrane
segments on the exoplasmic side of the membrane, whereas
large domains and segments connect some of the transmembrane
segments on the cytoplasmic side (Figures 1, 2). Recent
studies suggest that transmembrane segments M1–M6 form the
principal unit for transport of phospholipids across membranes
with M7–M10 playing a supporting role (Baldridge and Graham,
2012; Vestergaard et al., 2014). P4-ATPases also contain
regulatory domains that modulate the transport activity and
targeting domains that participate in the trafficking of the
P4-ATPases to their preferred subcellular membranes. These
domains are present, at least in part, along the cytoplasmic
C-terminal and N-terminal segments of P4-ATPases, but to date
are poorly characterized for mammalian P4-ATPases (Takatsu
et al., 2011; Zhou et al., 2013).
CDC50–ACCESSORY SUBUNIT
P4-ATPases with the exception of ATP9A and ATP9B assemble
with an accessory or β-subunit to form a heteromeric complex,
most likely a heterodimer. The β-subunit belongs to the
CDC50/LEM3 family of evolutionary conserved proteins present
in all eukaryotes (Katoh andKatoh, 2004; Saito et al., 2004). There
are three CDC50 proteins (CDC50A, CDC50B, and CDC50C,
also known as TMEM30A, TMEM30B, and TMEM30C) in
humans and three in yeast (Cdc50p, Lem3p, Crf1p). Since there
are more P4-ATPases (α-subunits) than CDC50 proteins (β-
subunits), many P4-ATPases associate with the same CDC50
protein to form the heteromeric complex (Bryde et al., 2010).
The interaction of mammalian P4-ATPases with specific
CDC50 proteins has been studied primarily by heterologous
protein co-expression and co-immunoprecipitation (Paulusma
et al., 2008; Bryde et al., 2010; Van Der Velden et al., 2010b;
Coleman and Molday, 2011; Takatsu et al., 2011, 2014; Naito
et al., 2015). These studies indicate that most mammalian P4-
ATPases use CDC50A as their β-subunit. These include ATP8A1,
ATP8A2, ATP11A, ATP11B, ATP11C, ATP10A, ATP10B, and
ATP10D. Several P4-ATPases including ATP8B1, ATP8B2, and
ATP8B4 can associate with either CDC50A or CDC50B. The
physiological consequence of this dual specificity, however,
remains to be determined. CDC50C is predominantly expressed
in testes (Osada et al., 2007), but to date it has not been
shown to associate with any P4-ATPase. Although, heterologous
overexpression provides useful information on the interaction
of P4-ATPases with specific CDC50 proteins, the presence of
such complexes needs to be confirmed in physiologically relevant
cells and tissues. In one study ATP8A2 was found to interact
with CDC50A in photoreceptors in support of heterologous cell
expression and immunoprecipitation studies (Coleman et al.,
2009; Coleman and Molday, 2011).
CDC50 proteins are relatively small membrane glycoproteins
containing approximately 350 amino acids. They consist of two
transmembrane segments joined by a large exoplasmic domain
with two ormore N-linked oligosaccharide chains that contribute
to the stability of the protein (Coleman and Molday, 2011;
Garcia-Sanchez et al., 2014; Figure 1B). CDC50 proteins typically
migrate on SDS gels as a broad band with an approximate
molecular mass of 50 kDa due to the highly heterogeneous
nature of the oligosaccharide chains. The exoplasmic domain
also contains four conserved cysteine residues that stabilize
the structure through the formation of two disulfide bonds
(Puts et al., 2012). Relatively, short N-terminal and C-terminal
segments are exposed on the cytoplasmic side of the membrane.
Heterologous expression studies point to the crucial role of
CDC50 in protein folding and formation of a functionally active
P4-ATPase complex (Paulusma et al., 2008; Bryde et al., 2010;
Van Der Velden et al., 2010b; Coleman andMolday, 2011). In the
absence of CDC50 expression, P4-ATPases fail to exit the ER and
are incapable of undergoing phosphorylation or phospholipid-
dependent ATP hydrolysis (Lopez-Marques et al., 2010; Coleman
and Molday, 2011; Puts et al., 2012). Likewise, in the absence of
P4-ATPase expression, CDC50A is retained in the ER of cells.
However, co-expression of P4-ATPases and CDC50 results in a
P4-ATPase-CDC50 complex that can exit the ER and function
as an active phospholipid flippase (Coleman and Molday, 2011).
CDC50 proteins do not play a direct role in the targeting of P4-
ATPases to their preferred subcellular location once they exit the
ER in multicellular organisms (Lopez-Marques et al., 2010).
Several studies suggest that CDC50 proteins participate in
ATP-dependent phospholipid transport. The affinity of yeast
Drs2p for Cdc50p fluctuates during the catalytic reaction
cycle with the highest affinity observed for Drs2p in the
E2P state with a bound phospholipid substrate (Lenoir et al.,
2009). Phosphorylation of Drs2p, ATP8B1, and ATP8B2 are
dependent on interaction with their CDC50 subunit (Lenoir
et al., 2009; Bryde et al., 2010). Studies using mammalian
CDC50A/CDC50B chimeric proteins further indicate that both
the transmembrane and exoplasmic domains of CDC50A are
necessary for the binding CDC50A to ATP8A2 and the formation
of an active complex (Coleman and Molday, 2011). The N-
terminal cytoplasmic domain of CDC50A also modulates the
kinetics of ATP8A2 ATPase activity.
Certain mutations in the transmembrane segments of
ATP8A2 decrease glycosylation of CDC50 without significantly
affecting the functional properties of the complex and seem to
define a groove betweenM1,M3, andM4 of ATP8A2 as a possible
location of CDC50 interactions (Vestergaard et al., 2015; see later
text in relation to Figure 6). Altogether, the available information
indicates that CDC50 accessory proteins contact P4-ATPases at
multiple sites to promote correct protein folding, exit of the P4-
ATPase complex from the ER, and formation of a functionally
active flippase complex. Hence, CDC50 proteins appear to
play a role reminiscent of the β-subunits of Na+/K+-ATPases
(Puts and Holthuis, 2009). Because E2P is the state, in which
the P4-ATPase is supposed to bind its phospholipid substrate
from the exoplasmic membrane leaflet (see reaction cycle in
Figure 3B), the preferential interaction of the CDC50 protein
with E2P (Lenoir et al., 2009) is consistent with participation
of CDC50 in substrate loading analogous to the role of the
β-subunit of Na+/K+-ATPase in K+ binding (Shinoda et al.,
2009). Nevertheless, CDC50 and the β-subunit of Na+/K+-
ATPase differ with respect to the number of transmembrane
segments (two for CDC50 and only one for the Na+/K+-ATPase
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FIGURE 1 | Continued
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FIGURE 1 | Continued
Phylogenetic analysis and membrane topology of P4-ATPases. (A) The sequences of the 14 human P4-ATPases were aligned using the Clustal Omega
multi-sequence alignment program for generation of the phylogenetic tree. Protein sequences are from the following accession numbers: ATP8A1 (Q9Y2Q0); ATP8A2
(Q9NTI2); ATP8B1 (O43520); ATP8B2 (P98198); ATP8B3 (O60423); ATP8B4 (Q8TF62); ATP9A (O75110); ATP9B (O43861); ATP10A (O60312); ATP10B (O94823);
ATP10D (Q9P241); ATP11A (P98196); ATP11B (Q9Y2G3); ATP11C (Q8NB49); (B) The cytoplasmic A (“actuator”), N (nucleotide binding), and P (phosphorylation)
domains of the α-subunit are shown as colored circles. Conserved motifs involved in phosphorylation (DKTGT) and dephosphorylation (DGET) are indicated for the
respective domains. The 10 transmembrane helices of the α-subunit are represented by cylinders (M1 kinked), M1–M2 purple, M3–M4 green, M5–M6 brown, and
M7–M10 gray. The two transmembrane helices of the β-subunit (CDC50 protein) are shown as red cylinders. Glycosylation and disulfide bridges of the exoplasmic
domain of the β-subunit are also indicated. The C-terminal cytoplasmic extension of the α-subunit furthermore contains a regulatory domain shown as cyan cylinder (R
domain).
β-subunit), the phylogenetic origin, and apparently also the α-
subunit contact sites (M7 and M10 for the Na+/K+-ATPase; a
groove between M1, M3, and M4 for ATP8A2).
Class 2 P4-ATPases (ATP9A and ATP9B in mammals and
Neo1p in yeast) do not appear to use CDC50 proteins as β-
subunits. Both ATP9A and ATP9B exit the ER and localize
to their respective cell membranes in the absence of CDC50
proteins (Takatsu et al., 2011). Neo1p is the only yeast P4-
ATPase that is lethal when its gene is deleted pointing to its
essential role in yeast survival (Prezant et al., 1996; Hua et al.,
2002). Neo1p forms a complex with Ysl2p, a guanine nucleotide
exchange factor for Arl1p that functions in vesicle trafficking
within the Golgi/endosomal system (Wicky et al., 2004; Barbosa
et al., 2010). The function of ATP9A and ATP9B is not known
and it remains to be determined if these P4-ATPases require an
accessory subunit or associated protein for activity and whether
they transport phospholipids across membranes.
DISTRIBUTION OF P4-ATPases IN CELLS
The subcellular localization of mammalian P4-ATPases has
been mostly studied by immunofluorescence microscopy and
transport of fluorescently labeled phospholipids into cells
overexpressing the protein complex. Although, there is some
variation possibly due to the cell type used or extent
of overexpression, in general several P4-ATPases including
ATP11C, ATP11A, ATP10A, ATP10D, ATP8B1, ATP8B2, and
ATP8B4 in association with their β-subunit preferentially localize
to the plasma membrane of cells where they transport specific
phospholipids from the extracellular to the cytoplasmic leaflet
(Van Der Velden et al., 2010b; Takatsu et al., 2011, 2014; Naito
et al., 2015). Of these P4-ATPases, ATP11C has been widely
studied and shown to play a critical role in the internalization
of PS thereby preventing its exposure on cell surfaces (Yabas
et al., 2011, 2014; Segawa et al., 2014). The P4-ATPases
ATP8A1, ATP8A2, ATP10B, and ATP11B are largely confined to
Golgi/recycling endosomal systemwhen overexpressed in culture
cells (Coleman and Molday, 2011; Takatsu et al., 2011; Lee et al.,
2015). However, in some studies, several of these P4-ATPases
have been reported to be also present on the plasmamembrane of
cells (Segawa et al., 2016). ATP8A2 has been shown to transport
fluorescently labeled PS into cells and prevent exposure of PS
on cell surfaces. ATP8A1 localizes to the plasma membrane
of erythrocytes (Soupene and Kuypers, 2006). Taken together,
these studies indicate that P4-ATPases can cycle between the
Golgi/endosomal recycling system and the plasma membrane,
but preferentially localize to either the plasma membrane or
Golgi-recycling endosome network depending on the specific
P4-ATPase.
The subcellular localization of the Class 2 P4-ATPases, ATP9A
and ATP9B, has also been studied by overexpression in Hela
cells (Takatsu et al., 2011). ATP9A localizes to early/recycling
endosomes and the trans-Golgi network (TGN), whereas ATP9B
localizes exclusively to the TGN. A chimeric ATP9 protein in
which the N-terminal cytoplasmic region of ATP9A was replaced
with the corresponding region of ATP9B localized exclusively
to the TGN indicating that a segment within the N-terminal
cytoplasmic region of ATP9 proteins is responsible for subcellular
localization. ATP9A is highly expressed in neural and pancreatic
tissue whereas ATP9B is more ubiquitously expressed. Recently,
ATP9A has been reported to be present in human and rat
pancreatic islets and based on membrane fractionation appears
concentrated in the plasma membrane (Ansari et al., 2015).
ATP9A, like other P4-ATPases may cycle between the TGN and
plasma membrane of cells.
It should be noted, however, that protein overexpression
can result in abnormal localization in cells. Accordingly, it will
be important to examine the distribution of endogenous P4-
ATPases in physiologically relevant tissues and cells. A set of
highly specific antibodies to the various P4-ATPases would be
particularly valuable to probe their distribution in various cells
and tissues.
PHOSPHOLIPID SUBSTRATE SPECIFICITY
The substrate specificities for only a few mammalian P4-ATPases
have been determined at a biochemical level with most being
specific for the aminophospholipids, PS and PE (Table 1).
Historically, aminophospholipid translocase (APLT) activity was
first found in red blood cells and bovine chromaffin granules
(Moriyama and Nelson, 1988; Morrot et al., 1990; Zimmerman
and Daleke, 1993; Auland et al., 1994; Tang et al., 1996). The
membrane protein responsible for this activity was identified as
ATPaseII (now known as ATP8A1) (Mouro et al., 1999; Paterson
et al., 2006). Expression in insect cells and yeast confirmed
the activation of the ATPase activity of ATP8A1 by PS and
more moderate activation by PE (Ding et al., 2000; Paterson
et al., 2006; Soupene et al., 2008). More recently, ATP8A1
expressed and purified from HEK293 cells and reconstituted
into liposomes has been confirmed to flip PS and to a lesser
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FIGURE 2 | Amino acid sequence alignment of P4-ATPases and P-type ion pumps. Sequences of two P4-ATPases, bovine ATP8A2 (UniProt: C7EXK4) and
human ATP8B1 (UniProt: O43520), are shown aligned with sequences of the P2- and P3-ATPases shark Na+/K+-ATPase (UniProt: Q4H132, PDB: 2ZXE), plant
AHA2 H+-ATPase (UniProt: P19456, PDB: 3B8C), and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) isoform 1a (UniProt: P04191, PDB: 3B9B). Letter colors
(Continued)
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FIGURE 2 | Continued
denote positively (blue) or negatively (red) charged, polar (green), or hydrophobic (black) residues. Membrane parts of transmembrane helices of SERCA identified in
the crystal structure are indicated by gray shading with helix numbering and indication of exoplasmic loops under the sequence. Arrowheads with residue number
above the bATP8A2 sequence indicate some of the residues that are mentioned in the text or shown in the figures. Arrowheads below the SERCA sequence indicate
residues of SERCA or the Na+/K+-ATPase involved in binding the ions transported by these ATPases. This alignment was based on a previously described multiple
sequence alignment (Vestergaard et al., 2014).
extent PE across membranes (Lee et al., 2015). While ATP8A1
is widely expressed in different mammalian tissues, the second
member of the ATP8A subgroup, ATP8A2, is most highly
expressed in retina, brain, spinal cord, and testes (Coleman
et al., 2009; Cacciagli et al., 2010; Zhu et al., 2012). ATP8A2 has
been purified from retinal photoreceptor cells and transfected
HEK293 cells for analysis of its ATPase and phospholipid flippase
activity (Coleman et al., 2009, 2012; Coleman and Molday,
2011). Like ATP8A1, ATP8A2 preferentially transports PS across
membranes, but can also uses PE as a substrate. Functional
complementation experiments further show that ATP8A2 can
rescue defects in ATP8A1-depleted cells indicating that ATP8A1
and ATP8A2 share overlapping functional activities (Lee et al.,
2015).
While the PS substrate specificity of the ATP8A subclass
of P4-ATPases has been confirmed by multiple investigations,
the results with respect to the ATP8B proteins have been less
definitive. ATP8B1 has been implicated in hepatic disorders
such as progressive familial intrahepatic cholestasis (PFIC) and
benign recurrent intrahepatic cholestasis (BRIC) (Bull et al.,
1998; Eppens et al., 2001). As a result, it has been one of the most
studied of the mammalian P4-ATPases. Initial evidence based
on increased biliary excretion of PS in ATP8B1 deficient mice,
plasma membrane uptake of fluorescent PS, and higher exposure
of PS on the outer plasma membrane leaflet in the absence of an
active flippase complex implicated ATP8B1 in the flipping of PS
across the plasma membrane (Paulusma et al., 2006, 2008). But
the results presented in a more recent study point toward PC as
being the primary transport substrate of ATP8B1 (Takatsu et al.,
2014). The same study also found that ATP8B1 mediated uptake
of a NBD-labeled PC analog could be negated by concomitant
expression of ABCB4, an ABC transporter that mediates ATP-
dependent transport of phospholipids to the extracellular leaflet
of plasma membranes. The substrate specificity of the other
ATP8B members has not been studied at a biochemical level.
Cell based studies, however, suggest that ATP8B2 like ATP8B1
transports PC (Takatsu et al., 2014). ATP8B3 has been implicated
in the transport of PS, but the substrate specificity for this
flippase requires further study (Wang et al., 2004; Gong et al.,
2009). ATP8B5 is present in mice but not humans, and has been
implicated in spermatogenesis, but the phospholipid substrate
remains to be determined (Xu et al., 2009).
The structural basis for the reported difference in substrate
specificity between Class 1a and Class1b P4-ATPases has not
been elucidated. Although, the amino acid sequences of the
transmembrane segments of ATP8A2 and ATP8B1 only exhibit
33% sequence identity, most of the positively charged residues in
ATP8A2 that may interact preferentially with the net negatively
charged head group of PS are conserved in ATP8B1 (Figure 2,
Naito et al., 2015). Subtle structural differences of the α subunits,
matching the translocation pathway with the size and hydrogen
bonding pattern, rather than the net charge of the head group,
could be decisive for the substrate specificity, which might also
depend on differences in the interaction of the α-subunit with the
CDC50 protein. It is of note that most of the amino acid residues
with a suggested role in determining the respective PS and PC
specificities of the yeast flippases Drs2p and Dnf1p (Baldridge
and Graham, 2012, 2013) are not conserved in the mammalian
P4-ATPases with corresponding substrate specificity (Naito et al.,
2015).
The substrate specificity of ATP11A and ATP11C has also
been investigated (Takatsu et al., 2014). These P4-ATPases,
like ATP8A1 and ATP8A2, flip PS as their primary substrate
confirming earlier results showing that ATP11C is involved
in PS translocation into B-lymphocytes and other immune
cells (Yabas et al., 2011, 2016; Segawa et al., 2014). Substrate
specificity of ATP10A has recently been reported (Naito et al.,
2015). Exogenously expressed ATP10A localizes to the plasma
membrane in HeLa cells and produces a significant increase in
the uptake of fluorescent NBD-PC, but not other phospholipids.
This internalization of PC was not observed in cells expressing an
ATPase deficient form of ATP10A.
It needs to be pointed out that aside from ATP8A1 and
ATP8A2 reports about the transport substrates of most other
mammalian P4-ATPases are based on the ability of cells
expressing these proteins to ingest fluorescent phospholipid
analogs. This experimental setup is open to the introduction
of some confusion regarding the exact nature of the substrate
specificity of flippases as seen with the yeast plasma membrane
flippases. Greater clarity in this regard is expected to evolve in the
future from biochemical characterization of purified proteins.
P4-ATPases expressed in the yeast, Saccharomyces cerevisiae,
historically have been themost well characterizedmembers of the
P4-ATPase family. Drs2p, one of the first phospholipid flippases
to be identified, localizes to the TGN and endosomes, where it
transports PS and PE from the lumenal to the cytoplasmic leaflet
of membranes. Characterization of Drs2p flippase activity was
initially based on the results of experiments which looked at
the transport of fluorescent (NBD)-labeled PS and PE analogs
across TGN membranes purified from yeast strains expressing
either the wild type or a temperature sensitive Drs2p mutant
(Natarajan et al., 2004). These results were confirmed in direct
flippase assays using purified and reconstituted Drs2p (Zhou
and Graham, 2009). The TGN membrane shows expression
of another P4-ATPase, Dnf3p, which is also involved in
transmembrane transport of PS and PE as determined from the
loss of asymmetric distribution of fluorescent analogs in the
secretory vesicles of dnf31 cells (Alder-Baerens et al., 2006). Loss
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of both Drs2p and Dnf3p dissipates the asymmetric distribution
of aminophospholipids in the membranes of TGN and secretory
vesicles. Recent mutational analysis has revealed the ability
of Drs2p to distinguish between the mono- and di-acylated
phospholipid substrate molecules (Baldridge et al., 2013). On the
other hand, the two yeast flippases that localize to the plasma
membrane, Dnf1p and Dnf2p, have been implicated in the
flipping of PE and PC (Pomorski et al., 2003; Stevens et al., 2008).
Although, the initial study had suggested that these two proteins
might have a role in maintaining the asymmetric distribution of
PS in the plasma membrane, it was subsequently shown that they
are not essential for this function. In fact, the study by Stevens
et al. (2008) found that net internalization of PS increases in
dnf11dnf21 yeast strain, probably due to the enhanced activity
of other flippases.
REGULATION OF P4-ATPase ACTIVITY
The mechanism of P4-ATPase regulation has been examined
most thoroughly in yeast. The activity of Drs2p is regulated
by multiple mechanisms depending on the particular
endomembrane system. The C-terminal domain of Drs2p
contains a segment of basic amino acids (RMKKQR) that has
sequence homology to a split PH domain (Natarajan et al., 2009).
Drs2p interacts with the phosphatidylinositol-4-phosphate
(PI4P) through this domain and this interaction is required for
PS flippase activity (Natarajan et al., 2009). The PI4P binding
domain in the C-terminal domain of Drs2p overlaps with the
binding site of another regulatory element of flippase activity, the
Arf-GEF protein Gea2p (Chantalat et al., 2004; Natarajan et al.,
2009). As in the case of PI4P, the activity of Drs2p is abolished
in the absence of interactions with Gea2p. The requirement
for binding of these two regulatory molecules for activation of
Drs2p is removed upon cleavage of the C-terminal domain of
the protein (Zhou et al., 2013). It has been proposed that the
C-terminal domain of Drs2p acts as an auto-inhibitory domain
by interfering with the catalytic domains of the protein. Binding
of either PI4P or Gea2p disengages the auto-inhibitory domain
from the catalytic domain resulting in Drs2p flippase activity.
Along with binding to Gea2p at the C-terminal domain, Drs2p
also binds to Arl1p at the N-terminal domain. Formation of
this trimeric complex is required for flippase activity and for
recruitment of cargo during vesicle formation at the TGN (Tsai
et al., 2013). While Drs2p interacts with Gea2p at the TGN,
it interacts with the F-box protein Rcy1p at an overlapping
domain in early endosomes. This interaction is required for the
recycling of cargo between endosomes and the TGN (Hanamatsu
et al., 2014). The early endosome to TGN retrieval pathway also
includes the interaction between Drs2p and Arf-GAP protein
Gcs1p (Sakane et al., 2006). The two different interactions
of Drs2p with Rcy1 and Gcs1 at the early endosomes may
be required for the recruitment of different types of adaptor
molecules during the formation of recycling vesicles destined to
different membranes.
Apart from the binding of regulatory molecules, the
activity of P4-ATPases is also regulated by phosphorylation
and sphingolipid concentration. The activity of yeast plasma
membrane localizing P4-ATPases, Dnf1p and Dnf2p, requires
phosphorylation by kinase proteins, Fpk1 and Fpk2 (Nakano
et al., 2008). Deletion mutants for both Fpk1 and Fpk2
(fpk1∆fpk2∆) eliminated the plasma membrane uptake of NBD-
labeled phospholipids though the flippases localized normally to
the membrane. The activity of Fpk1 and Fpk2 is further regulated
by the kinase, Ypk1p. Hence, Ypk1-catalyzed phosphorylation of
Fpk1/2 eliminates the activity of these proteins, and the activity
of Ypk1 in turn is inhibited due to the phosphorylation by
Fpk1/2 proteins. The activity of Fpk1/2 proteins is stimulated
by presence of sphingolipids in the membrane. Thus, membrane
sphingolipids positively modulate the flippase activity of Dnf1p
and Dnf2p (Roelants et al., 2010). Apart from Ypk1, the
flippase activity of Dnf1p and Dnf2p is also negatively controlled
by Gin4p which phosphorylates Fpk1 to suppress its activity
(Roelants et al., 2015).
Little is known about the regulation of mammalian P4-
ATPase flippase activity. From limited studies, we know that the
flippase activities of ATP11A and ATP11C are down regulated
by exposure to calcium with an IC50 in the 100–200 µM range
(Segawa et al., 2016). The activity of these two P4-ATPases has
also been shown to be suppressed by caspase mediated cleavage.
It is hypothesized that the aminophosopholipid translocation
activity at the plasma membrane is inactivated by this caspase
route during apoptotic exposure of PS (Segawa et al., 2014, 2016).
The effect of other regulatory mechanisms including kinase-
catalyzed phosphorylation, calcium sensor proteins, and lipids
remains to be investigated.
ROLE OF P4-ATPases IN CELL
PHYSIOLOGY
P4-ATPases play a critical role in many cellular processes
associated with the plasma membrane and intracellular
membranes. A key function of P4-ATPases is to establish and
maintain phospholipid asymmetry across membranes. This is
most evident for P4-ATPases that utilize PS and PE as substrates.
These P4-ATPases including ATP11 and ATP8 subclasses ensure
that the extracellular leaflet of the plasma membrane is devoid
of PS since exposure of this phospholipid on cell surfaces is
an “eat me” signal for ingestion by phagocytic cells. PS and PE
specific P4-ATPases also ensure that the cytoplasmic leaflet of
membranes is highly enriched in these aminophospholipids. This
enables cytoskeletal components, adaptor proteins and enzymes
to bind to these membranes where they can function in any of
a variety of processes such as cell signaling pathways, enzyme
regulation, metabolism, vesicle trafficking and cell motility
(Newton and Keranen, 1994; Huang et al., 2011; Lee et al., 2015).
The role of PC specific P4-ATPases is less clear, but the active
transport of PC to the cytoplasmic leaflet may be important
for maintaining the integrity of specialized membranes and/or
recruitment of specific PC binding proteins to the cytoplasmic
surface under defined conditions.
Although, the main function of P4-ATPases is to actively
transport phospholipids across membranes, it is possible that
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some cellular functions of P4-ATPases are ATP-independent
(Van Der Velden et al., 2010a). Other P-type ATPases
including Na+/K+ ATPases are known to bind intracellular
and extracellular proteins and hence serve as a scaffold for
protein-protein interactions distinct from their ATP-dependent
ion transport function (Xie and Cai, 2003; Liang et al., 2007;
Molday et al., 2007). ATP-independent functions of P4-ATPases
have not been explored in detail, but it is plausible that some
P4-ATPases may serve as scaffolds for cell signaling or vesicle
trafficking through protein-protein interactions. An overview of
some key cellular functions of some mammalian P4-ATPases is
given below.
PS-ASYMMETRY IN BLOOD CELLS
The erythrocyte plasma membrane has been most extensively
studied and shown to exhibit a high degree of aminophospholipid
asymmetry (Daleke and Huestis, 1989). Early studies showed
that ATP8A1 is present in mature erythrocytes and as a result
this P4-ATPase was thought to be crucial in restricting PS to
the inner leaflet of erythrocytes (Soupene and Kuypers, 2006).
However, PS was not exposed on the surface of erythrocytes of
ATP8A1-deficient mice and the shape of erythrocytes appeared
normal suggesting that increased expression of other P4-ATPases
including ATP8A2 may compensate for the absence of ATP8A1
(Levano et al., 2012). Exposure of PS on the external surface
of hippocampal neurons of ATP8A1 knockout mice, however,
was observed, which correlates with impaired hippocampus-
dependent learning. These studies suggest that some cells
express other P4-ATPases that can compensate for the loss
of ATP8A1 whereas other cells such as hippocampal neurons
require ATP8A1 to maintain PS asymmetry.
Studies of ATP11C-deficient mice have provided strong
evidence for a crucial role of ATP11C in establishing PS
asymmetry in developing erythrocytes (Yabas et al., 2014).
ATP11C-deficient mice were found to display reduced uptake
of fluorescently labeled PS by erythroblasts but not mature
erythrocytes. However, circulating erythrocytes accumulated PS
on their surface, displayed abnormal shape characteristic of
stomatocytosis, and had a shortened lifespan. These studies
indicate that ATP11C is critical in generating and maintaining
PS asymmetry during erythropoiesis, a process that is important
in generating normal mature erythrocytes. The high content
of PS and PE on the cytoplasmic leaflet of erythrocytes
may be important for the interaction of the spectrin-ankyrin
cytoskeletal network with the plasma membrane required
for maintaining the normal shape of erythrocytes whereas
the absence of PS on the exoplasmic leaflet of erythrocytes
is important in maintaining the normal lifespan of these
cells. ATP11C mediated internalization of PS has also been
shown to be crucial for differentiation of B lymphocytes
(Siggs et al., 2011a; Yabas et al., 2011).
PS asymmetry is also important in blood coagulation (Lentz,
2003). In this case retention of PS on the cytoplasmic leaflet of
platelets and other blood cells prevents blood coagulation from
occurring (Lentz, 2003; Lhermusier et al., 2011). This asymmetry
is established by one or more active P4-ATPases and an inactive
scramblase. In a proteomic screen, several P4-ATPases have
been identified in human platelets including ATP8A1, ATP8B2,
ATP11A-C, and ATP9B (Lewandrowski et al., 2009). Whether all
or only selective P4-ATPases contribute to PS asymmetry remains
to be determined. Blood coagulation is initiated when the
bidirectional scramblase TMEM16F is activated by an increase
in the intracellular Ca2+ concentration leading to PS exposure
on platelet cell surfaces (Suzuki et al., 2010; Lhermusier et al.,
2011; Malvezzi et al., 2013; Brunner et al., 2014). As part
of this process, P4-ATPases may also be inhibited directly or
indirectly by an increase in intracellular Ca2+, although this
remains to be determined. Coagulation factors including Factor
V can bind to the surface exposed PS through their discoidin
domains to initiate the blood coagulation cascade. Loss-of-
functionmutations in TMEM16F have been shown to cause Scott
syndrome, a severe bleeding disorder supporting the role of this
scramblase in PS exposure and the blood coagulation process
(Lhermusier et al., 2011).
PS-ASYMMETRY IN APOPTOSIS
Apoptosis is another well-established process involving the
interplay of P4-ATPases and scramblases (Segawa et al., 2014;
Hankins et al., 2015). The exposure of PS on the surface of
cells is an “eat me” signal for phagocytic cells to engulf the
apoptotic cell. Xkr8, a member of the XK family of membrane
proteins, has been implicated as the scramblase that exposes
PS on apoptotic cells for engulfment by macrophages (Suzuki
et al., 2013). ATP11C plays a key role in restricting PS to the
inner leaflet of the plasma membrane of normal cells. Cleavage
of ATP11C at multiple caspase sites can inactivate ATP11C
thereby facilitating apoptosis. Mutations in ATP11C that prevent
caspase cleavage, but retain PS transport activity, do not expose
PS on the surface of cells and these cells are not ingested by
macrophage (Segawa et al., 2014). However, ATP11C is not the
only P4-ATPase which is important in preventing PS exposure
on cell surfaces. In some cells ATP11A with a similar substrate
specificity and plasma membrane localization as ATP11C can
compensate for the loss of ATP11C and prevent exposure of PS
on cell surfaces (Segawa et al., 2016). Like ATP11C, ATP11A has
a number of caspase cleavage sites. These studies suggest that
the activation of the scramblase together with inhibition of P4-
ATPases may be required for exposure of PS on cells as a signal
for apoptosis.
P4-ATPases IMPLICATED IN
INTRACELLULAR VESICLE TRAFFICKING
In addition to playing a role in establishing phospholipid
asymmetry in the plasma membrane, P4-ATPases also play
a crucial role in generating phospholipid asymmetry in
intracellular membranes, a process linked to vesicle trafficking
in cells. Most membrane lipids are synthesized on the
cytoplasmic side of the ER and redistributed symmetrically
across the membrane by scramblases. Vesicles budding from
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the ER fuse with the Golgi complex. Lipid asymmetry is
induced in the TGN through the action of active flippases
and floppases. Most information on the role of P4-ATPases
in vesicle trafficking comes from studies of the yeast P4-
ATPase Drs2p by Graham and colleagues (Sebastian et al.,
2012). Drs2p is localized to the TGN where it flips PS and
PE to the cytoplasmic leaflet to generate aminophospholipid
asymmetry (Hua et al., 2002; Natarajan et al., 2004). The flippase
activity of Drs2p is thought to initiate membrane curvature
by increasing PS and PE content on the cytoplasmic leaflet
at the expense of the lumenal leaflet leading to membrane
curvature as initially proposed in the coupled bilayer hypothesis
of Sheetz and Singer (1974) and Xu et al. (2013). Membrane
curvature together with the increase in the negatively-charged
PS recruits Arf-GTPase-activating protein Gcs1 and clathrin
coat proteins to the cytoplasmic leaflet as part of the vesicular
transport process between the TGN and early endosomes
(Sebastian et al., 2012).
P4-ATPases have also been implicated in vesicle budding and
trafficking in other eukaryotic cells although the mechanism is
poorly understood. ATP8A2 is crucial for axon elongation in
PC12 cells and hippocampal neurons suggesting a role of this P4-
ATPase in vesicle trafficking required for neurite extension (Xu
et al., 2012). Similarly, ATP8A2 deficient mice show a striking
loss in the length of photoreceptor outer segments suggesting
that a decrease in vesicle trafficking between the inner and outer
segment of these cells occurs in the absence of ATP8A2 (Coleman
et al., 2014). More recently, Lee et al. have shown that ATP8A1-
catalyzed flipping of PS in recycling endosomes is important in
the recruitment of EHD1 to the cytoplasmic leaflet of recycling
endosomes and membrane fission (Lee et al., 2015). Finally,
ATP8A1 has been associated with cell migration (Kato et al.,
2013).
ROLE OF P4-ATPases IN HUMAN DISEASE
To date, two P4-ATPases, ATP8B1 and ATP8A2, have been
directly associated with human genetic disorders. Mutations in
the ATP8B1 are responsible for two related liver diseases, known
as benign recurrent intrahepatic cholestasis type 1 (BRIC1)
and the more severe form progressive familial intrahepatic
cholestasis type 1 (PFIC1) (Bull et al., 1998). These early onset
diseases are characterized by impaired bile flow or cholestasis.
Affected individuals can also experience hearing loss and are
more susceptible to pneumonia (Stapelbroek et al., 2009; Ray
et al., 2010). ATP8B1 has been localized to the canalicular
membrane where it is thought to function as a phospholipid
flippase to maintain the integrity of the membrane (Folmer
et al., 2009b). This is supported in studies defining the effect
of ATP8B1 knockdown on cultured rat hepatocytes (Cai et al.,
2009). Loss in ATP8B1 resulted in normal ABCB4 expression
and localization to the canalicular membrane, but impaired
bile secretion and aberrant microvilli morphology. In Caco-2
cells, loss in ATP8B1 expression also causes significant reduction
in microvilli supporting a role of ATP8B1 in maintaining the
apical membrane structure. The effect of missense mutations
associated with PFIC1 and BRIC1 on the stability of ATP8B1 and
its interaction with CDC50A was studied in transfected CHO
cells (Folmer et al., 2009b). The mutants were found to be less
stable than the wild-type proteins and show a loss or decreased
interaction with CDC50A. Furthermore, the mutants were not
detected on the canalicular membrane of WIF-B cells. The
impaired targeting to the plasma membrane of ATP8B1 caused
by the most frequent ATP8B1 disease mutation in European
patients, I661T, was recently shown to be rescued by compounds
known to be efficient correctors of CFTR misfolding in cystic
fibrosis, thus pointing to a possible therapeutic strategy (Van
Der Woerd et al., 2016). The mechanism by which loss in
ATP8B1 leads to cholestasis is poorly understood, but it has
been proposed that increased PS on the luminal leaflet on
canalicularmembranes due to the loss in ATP8B1 flippase activity
results in abnormal lipid packing (Folmer et al., 2009a). This
in turn makes the outer leaflet of the canalicular membrane
susceptible to bile salt mediated extraction of cholesterol and
phospholipids resulting in reduced activity of ABCB11, a major
bile salt exporter that has also been linked to PFIC2 (Strautnieks
et al., 1998). The recent studies suggesting that ATP8B1 is a PC
and not a PS flippase, however, leaves this model open to further
investigations. It is possible that deficiency in PC transport to
the inner membrane of canalicular membranes due to mutations
in ATP8B1 could compromise the stability of the membrane to
bile salts. More studies are needed to further define the role of
ATP8B1 in cholestasis.
Genetic defects in ATP8A2 have been reported in two
families. One individual with mental retardation and hypotonia
had a balanced translocation of chromosomes 10 and 13
which disrupted the coding sequence of the ATP8A2 gene
(Cacciagli et al., 2010). More recently, a missense mutation
(I376M) was identified as the cause of a rare neurodegenerative
disease known as cerebellar ataxia, mental retardation, and
dysequilibrium syndrome (CAMRQ) in a consanguineous family
from Turkey (Onat et al., 2012). The I376M mutation is
present in a conserved region of the M4 transmembrane
segment of ATP8A2. Biochemical characterization confirmed
that this missense mutation results in the loss in ATP8A2 PS
flippase activity, as further discussed below (Vestergaard et al.,
2014). Two ATP8A2-deficient mouse models, wabbler-lethal (wl)
mouse and ATP8A2 knockout mouse, show similar neurological
abnormalities including body tremors and ataxia resulting from
distal axonal degeneration of the spinal cord (Zhu et al., 2012;
Coleman et al., 2014). The wl mouse has a deletion in exon
22 of Atp8a2 resulting in the expression of an inactive protein
(Zhu et al., 2012). In addition to these characteristics, ATP8A2
deficient mice exhibit a loss in visual and auditory function
and degeneration of photoreceptor and spiral ganglion cells
(Coleman et al., 2014). These studies indicate that ATP8A2 plays
an essential role in the function and survival of many neuronal
cells, possibly by contributing to vesicle trafficking in axons and
related neurological structures.
More limited information is available on the role of other
P4-ATPases in human diseases (Van Der Mark et al., 2013).
ATP10A has been implicated in the control of insulin-mediated
glucose uptake in mouse adipose tissue and skeletal muscle
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and is considered as a risk factor for Type 2 diabetes in
African-Americans (Dhar et al., 2004, 2006). ATP11A has
been suggested to be a predictive marker for prognosis of
colorectal cancer (Miyoshi et al., 2010). ATP11C-deficient mice
have been shown to exhibit multiple abnormalities including
loss in B cell development, hyperbilirubinemia, hepatocellular
carcinoma, and anemia (Siggs et al., 2011a,b; Yabas et al., 2011).
It remains to be determined if loss of function mutations
in human ATP11C cause similar disorders. ATP8B4 has been
implicated in Alzheimer’s disease based on its chromosomal
localization and analysis of single-nucleotide polymorphisms
(Li et al., 2008).
STRUCTURAL AND MECHANISTIC
FEATURES OF P4-ATPases
Reaction Cycle of P4-ATPases
The predicted domain structure and topology together with
conserved motifs for phosphorylation and dephosphorylation
(Figures 1, 2) argue in favor of a flippase mechanism related
to the well-known mechanism of the P2-ATPase ion pumps
Ca2+-ATPase and Na+/K+-ATPase. Indeed, like the P2-ATPases
and, presumably, all other P-type ATPases, the P4-ATPases
are phosphorylated in a vanadate-sensitive manner by ATP at
the conserved P-domain aspartate (Ding et al., 2000; Lenoir
et al., 2009; Bryde et al., 2010; Coleman et al., 2012). The
reaction cycle has been examined in some detail for ATP8A2
(Coleman et al., 2012), showing that the phosphoenzyme
exists in E1P and E2P states, and that the dephosphorylation
of E2P is activated by the specific phospholipid substrates
PS and PE, but not by PC (Figure 3A). The latter finding
is reminiscent of the effect of K+ binding from the external
side to the Na+/K+-ATPase (Post et al., 1972). The K+
activation of dephosphorylation is one of the key features
of the coupling mechanism of the Na+/K+-ATPase that
allows K+ translocation from the external side to the internal
side of the plasma membrane (Figure 3C). The specific
phospholipid substrate apparently acts on the P4-ATPase in
a similar way, promoting dephosphorylation in association
with the translocation of the lipid from the exoplasmic
to the cytoplasmic leaflet of the lipid bilayer (Figure 3B).
Approximately 50-fold higher ATPase activity is observed
for ATP8A2 in lipid vesicles containing 10% PS/90% PC
as compared with 100% PC, where the ATPase activity is
diminutive, and with PE the activation is also substantial
(Coleman et al., 2009, 2012; Coleman andMolday, 2011). Crystal
structures of the P2-ATPase ion pumps Na+/K+-ATPase and
Ca2+-ATPase have shown how the conserved glutamate of
the A-domain TGES motif (in P4-ATPases DGET) is brought
into the correct position for catalyzing the hydrolysis of the
aspartyl phosphoryl bond in the P-domain. This unique event
consists of a 90◦ rotation of the A-domain in relation to
the E1P–E2P transition followed by an additional, smaller
change of conformation elicited by the binding of the ion
to be transported from the exoplasm toward the cytoplasm
(Toyoshima, 2009; Palmgren and Nissen, 2011). Similar
structural changes are expected to result in dephosphorylation
of P4-ATPases. Accordingly, it was demonstrated for ATP8A2
that mutation of the conserved A-domain glutamate blocks
dephosphorylation (Figure 3A; Coleman et al., 2012). It is
noteworthy that the structural information from the P2-ATPases
shows that the catalytic site at which dephosphorylation
occurs is located some 50 Å from the membrane site at
which K+ binds to promote the dephosphorylation. In P4-
ATPases the corresponding distance is likely no less, with the
catalytic site being composed of the cytoplasmic A-, P-, and
N-domains, and the lipid substrate coming from the exoplasmic
leaflet, thus indicating that the signal transduction must take
place through a conformational change reaching over long
distance.
Kinetic Difference between ATP8A2 and
Drs2p
Dephosphorylation of the yeast homolog of ATP8A2, Drs2p,
is also accelerated by PS, but to a lesser extent than the
dephosphorylation of ATP8A2 and only in the simultaneous
presence of phosphatidylinositol-4-phosphate binding to the
C-terminal regulatory domain (Jacquot et al., 2012). This
observation is in accordance with the evidence mentioned
above that Drs2p requires such interaction for PS flippase
activity, thus being autoinhibited by the C-terminus in the
absence of the activator. The C-terminus likely interferes with
the optimal positioning of the A-domain for catalysis of
dephosphorylation (Montigny et al., 2016). However, even in the
presence of phosphatidylinositol-4-phosphate the PS-activated
ATP hydrolysis and dephosphorylation rates of Drs2p are 1–
2 orders of magnitude lower than those of ATP8A2 (Jacquot
et al., 2012). The ATP hydrolysis and dephosphorylation rates
determined for ATP8A2 are comparable to the rates seen
for Ca2+-ATPase and Na+,K+-ATPase (Coleman et al., 2012).
It has been suggested that the high catalytic turnover rate
of ATP8A2 is needed particularly in the retinal membranes
housing ATP8A2, due to rapid dissipation of lipid asymmetry
by the floppase activity of the retinal protein opsin (Jacquot
et al., 2012). However, ATP8A2 is expressed not only in
the retina, but all over the brain, where it is indispensable,
as evidenced by the CAMRQ syndrome resulting from a
single missense mutation of ATP8A2. Even in the presence
of its known activator Drs2p appears more autoinhibited
than ATP8A2. Worth noting in this connection is the fact
that there is only poor conservation between ATP8A2 and
Drs2p of the C-terminal tail including the putative RMKKQR
phosphatidylinositol-4-phosphate-binding site (Jacquot et al.,
2012). More information that possibly can be obtained by
studying the consequences of exchanging their C-termini is
needed to resolve this issue. The coupling between ATP
hydrolysis and lipid flipping should also be considered. The
stoichiometry of PS molecules flipped per ATP molecule
hydrolyzed has not been determined with confidence, one reason
being that the ATPase activity is rather low with the NBD-labeled
PS used for measurement of transport. It is thus an open question
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FIGURE 3 | Dephosphorylation of P4-ATPases and Na+/K+-ATPase is activated by binding of the transported substrate. (A) Experimental data (Coleman
et al., 2012) showing the accelerating effect of addition of phosphatidylserine (PS) on dephosphorylation of ATP8A2 (open circles). No dephosphorylation occurs when
phosphatidylcholine (PC) is added (open triangles). The PS-induced dephosphorylation is blocked by the E198Q mutation replacing the glutamate in the DGET motif
of the A domain with glutamine (filled triangles). (B) Reaction cycle of P4-ATPases proposed on the basis of the finding illustrated in A together with additional analysis
of the conformations of the phosphoenzyme intermediate of ATP8A2 (Coleman et al., 2012). (C) Classic Post-Albers model for the reaction cycle of Na+,K+-ATPase
(Post et al., 1972) illustrating that the activation of dephosphorylation of the P4-ATPase by PS (coming from the exoplasmic lipid bilayer leaflet) shown in (A,B) is
analogous to the activation of dephosphorylation of Na+,K+-ATPase by K+ (coming from the exoplasmic medium). Na+ binding from the cytoplasm is required for
phosphorylation of Na+,K+-ATPase, whereas no known ion or other substrate needs to bind to the P4-ATPase to allow phosphorylation (see text for more
explanation).
whether ATP8A2 hydrolyzes more ATP per lipid flipped than
Drs2p.
Phosphorylation of P4-ATPases Does Not
Need Triggering by Ions Being
Countertransported
In the Na+/K+-ATPase and the Ca2+-ATPase, the binding of the
ion being transported from the cytoplasmic to the exoplasmic
side triggers the phosphorylation from ATP (Figure 3C). It is
therefore relevant to ask whether the analogy between P4-ATPase
and P2-ATPase catalytic mechanisms further implies that the
binding of another specific substrate transported in the reverse
direction of the known lipid substrates, from the cytoplasmic to
the exoplasmic side, is needed to activate the phosphorylation
of the P4-ATPase from ATP. This question has been addressed
by examining the effects of various ions including Na+, K+,
Cl−, SO2−4 , Ca
2+, N-methyl-D-glucamine, acetate, and H+ on
the phosphorylation of ATP8A2 from ATP, with the result that
none of these ions promote phosphorylation at a significantly
higher rate than the others (Coleman et al., 2012). Similar results
were obtained for Drs2p in a study that tested in addition to
the ions mentioned above, Co2+, Zn2+, La3+, carbonyl cyanide,
m-chlorophenylhydrazone, oxalate, and arsenate, in all cases
without finding appreciable effects on phosphorylation (Jacquot
et al., 2012). Perhaps the most likely candidate for a non-lipid
substrate transported by the P4-ATPases toward the exoplasm
would be H+, but rapid kinetic analysis of the pH dependence
of the phosphorylation rate showed no significant variation in
the interval from pH 6.5 to pH 9.0, thus indicating that if proton
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binding at a specific site (supposedly followed by transport) really
were required for activation of the phosphorylation reaction,
then the proton affinity of this site would be unusually high
with deprotonation occurring only above pH 9.0 (Coleman et al.,
2012). The conclusion of these studies is therefore that presently
there are no ions known as activators of the phosphorylation of
P4-ATPases except for Mg2+, which is required as catalyst at the
catalytic site as for other P-type ATPases. The apparent affinity for
Mg2+ activation of phosphorylation is in the micromolar range
and very similar to that pertaining to Na+/K+-ATPase (Coleman
et al., 2012).
Pathway for Phospholipid Movement
Studied by Mutagenesis and Structural
Modeling
Giant Substrate Problem
While the catalytic mechanism of ATP hydrolysis by P4-ATPases
appears similar to that of the P2-type ATPases, these ion pumps
might be less suitable models for the P4-ATPases when it comes
to understanding the handling of the lipid substrate. The size
of the ions being transported by the P2-ATPases is only 2–
3 Å in diameter, allowing occlusion of the ions in a narrow
space between the transmembrane helices M4, M5, M6, and M8
during their passage across the membrane. Phospholipids are
much larger (the hydrocarbon chains are approximately 20 Å
long and the head group 5 Å), taking up space corresponding
to half the membrane bilayer thickness, and must reorient
during the flipping to keep the hydrophilic head group at
the bilayer surface. The large size of the lipid substrate and
the complex movement it has to undergo make it hard to
imagine a common transport mechanism for ions and lipids.
Solving this enigma, the so-called “giant substrate problem,” is a
most essential challenge of P4-ATPase research. Because flippase
activity is retained following purification and reconstitution of
ATP8A2 together with its accessory CDC50A subunit in lipid
vesicles (Coleman et al., 2009, 2012; Coleman andMolday, 2011),
there is no doubt that these are the only protein components
required for the movement of the lipid and its coupling with
ATP hydrolysis, thus providing a sound basis for using site-
directed mutagenesis to search for residues interacting with
the lipid substrate during the flipping. Mutational effects on
the apparent affinity for the lipid substrate can be assessed
from the PS or PE concentration dependences of the ATPase
activity and/or the dephosphorylation step. PS or PE is added
at various concentrations to the ATP8A2-CDC50A complex
maintained solubilized in detergent and PC. This procedure first
pinpointed the lysine K873 as critical for the interaction with
the lipid substrate (Coleman et al., 2009; Coleman and Molday,
2011; Coleman et al., 2012). The K873A and K873E mutants
showed conspicuous reductions of the apparent affinity for PS in
ATPase activity studies as well as in studies of the PS-activated
dephosphorylation, whereas a more moderate reduction was
seen for K873R, thus indicating a role of the positive charge
of the side chain, which might be to interact with a negative
charge of the phospholipid head group. Because the binding
of PE was disturbed as well by the mutation, the suggested
interaction would implicate the phosphate part of the head
group common to both lipids (Coleman et al., 2012). K873 is
located in the M5 transmembrane helix at exactly the position
corresponding to a serine in Na+/K+-ATPase that is a key residue
in the coordination of K+ during the transport (Blostein et al.,
1997; Pedersen et al., 1998; Shinoda et al., 2009). Moreover,
significant effects were observed for mutation of the adjacent
N874, which corresponds to an asparagine that participates in
the coordination of K+ in Na+/K+-ATPase and Ca2+ in the
Ca2+-ATPase (Coleman et al., 2012), see the sequence alignment
in Figure 2. Thus, the similarity between the P4-ATPase and
the P2-ATPases clearly reaches beyond the mechanism of ATP
hydrolysis, managed by the cytoplasmic domains, to the events
taking place in the membranous part of the protein.
Would it really be feasible that the giant phospholipid
substrate is translocated through a pathway in the protein that
involves occlusion between the transmembrane helices M4, M5,
M6, and M8 similar to the occlusion of ions being translocated
by the Na+/K+-ATPase and the Ca2+-ATPase? After all, this
possibility might not be totally unrealistic, because the crystal
structure of another related P-type ATPase ion pump, the plant
H+-ATPase AHA2 (P3-ATPase), unlike the crystal structures of
the Na+/K+-ATPase and the Ca2+-ATPase, shows the presence
of a large central cavity containing water (Pedersen et al.,
2007). The existence of this cavity is possibly the consequence
of the absence in the H+-ATPase transmembrane helices of
most of the negatively charged residues that in Na+/K+-ATPase
and Ca2+-ATPase cross-link the helices through the binding
of the transported cations. These carboxylic acid residues are
also absent in the P4-ATPases, being replaced by hydrophobic
residues in several cases (Figure 2). Hence, as long as structural
details of P4-ATPases in the membrane region remain unknown,
the option of a central cavity that might accommodate a
lipid temporarily during the flipping needs to be taken into
consideration. This hypothesis has also been referred to as a
“canonical binding site” (Baldridge and Graham, 2013), because
the lipid being flipped would be located similarly to the occluded
ions in the “classic” ion pumps.
Possible Peripheral Pathway
The alternative, and at the moment perhaps most realistic,
transport model is one in which a peripheral pathway in the
protein allows for flipping of the phospholipid in such a way
that only the polar head group interacts directly with the protein.
This would allow the hydrocarbon tail to slide through the
hydrocarbon layer of the lipid bilayer surrounding the protein,
sometimes referred to as the “credit card model” because the
interaction of the protein exclusively with the head group is
comparable to a credit card payment terminal, which touches
only the magnet stripe or chip of the card. The relevance of such
a peripheral pathway type of model is underscored by the recent
publication of the crystal structure of a scramblase, TMEM16
(Brunner et al., 2014). The scramblase equilibrates PS and PE
phospholipids between the two bilayer leaflets and contains at its
lipid bilayer exposed surface an 8–11 Å wide crevice spanning
the entire membrane. This crevice is formed by transmembrane
helices and is twisted like a spiral staircase with one side exposed
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FIGURE 4 | Structural model of ATP8A2 in E2P and E2 states revealing the hydrophobic gate pathway. The model was constructed on the basis of the
alignment of ATP8A2 with SERCA1a shown in Figure 2 and the crystal structures of SERCA1a in E2P and E2 states supplemented with refinement of the membrane
domain by molecular dynamics simulation, opening up a groove between M1, M2, M4, and M6 (Vestergaard et al., 2014). In all panels, the cytoplasmic side is up.
(A,B) Refined models of E2P and E2 states are shown in cartoon with helices M1–M2 in purple, M3–M4 in green, M5–M6 in brown, and M7–M10 as molecular
isosurface representation in gray. Selected hydrophobic side chains including I364 are shown in licorice representation with carbons in orange for hydrophobic
residues and in yellow for N359, nitrogen in blue, and oxygen in red. Water molecules in groove are red transparent spheres in the E2P model and cyan in the E2
(Continued)
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FIGURE 4 | Continued
model. (C) Metadynamics simulations were used to steer a phosphatidylserine molecule into the groove of the E2 model. (D) Visualization of credit card transport
hypothesis. E2 model in surface representation embedded in the phospholipid membrane, where brown spheres indicate phosphate parts of the phospholipid head
groups and hydrocarbon chains are shown in white (PC) or blue (PS) licorice representation. The hydrophilic head group of a PS molecule is being moved upwards
along the groove, partly solvated by water molecules (oxygen red, hydrogen white). The blue hydrocarbon chains of the lipid project into the membrane lipid phase.
to the membrane. Its surface is strongly hydrophilic, thus being
able to accommodate the head group of the phospholipid being
flipped, with the hydrocarbon tail extending into the surrounding
lipid bilayer in accordance with the “credit card model.”
Non-canonical Peripheral Pathway Model
A clue to where in the P4-ATPase structure a peripheral pathway
might be located was first obtained in studies of the yeast
P4-ATPases Dnf1p and Drs2p (Baldridge and Graham, 2012,
2013). The different lipid substrate specificities of these flippases
(PC and PS, respectively) allowed identification of amino acid
residues with a role in defining the substrate specificity by
examining chimeras and point mutants in which residues had
been exchanged betweenDnf1p andDrs2p. Critical residues were
pinpointed in themembrane region, particularly aM3 asparagine
(N550 of Dnf1p corresponding to N302 in bovine ATP8A2) and
a M4 phenylalanine/tyrosine (Y618 of Dnf1p corresponding to
L367 in bovine ATP8A2), as well as in M1 near its exoplasmic
end. Supposedly residues contributing to define the selectivity
for PC versus PS would be near a pathway for translocation of
the phospholipid head group, and the locations of the pinpointed
residues are not consistent with a central, canonical binding site.
Consideration of a structural model of Dnf1p based on the crystal
structure of the Ca2+-ATPase in the E1 state led to the conclusion
that these residues face the surrounding lipid phase in accordance
with a peripheral translocation pathway involving mainly M1,
M3, and M4, which was denoted as the “non-canonical pathway”
(Baldridge and Graham, 2012, 2013).
Hydrophobic Gate Peripheral Pathway Model
More recently, a slightly different location of a putative
peripheral pathway was suggested by structural modeling
prompted by mutagenesis results for other residues in M4,
particularly the isoleucine in the middle of M4 (Vestergaard
et al., 2014). This isoleucine is part of the PISL motif
(Figure 2), which is conserved among P4-ATPases. Significantly,
the isoleucine is located exactly at the position corresponding
to the glutamate in the corresponding PEGL motif of the
Ca2+-ATPase and the Na+/K+-ATPase. Like P4-ATPases,
P3-ATPases such as the AHA2 mentioned above have either
isoleucine or valine at the corresponding position (Figure 2). On
the basis of mutagenesis work in combination with structural
information from crystallization, the glutamate present in the
Na+/K+-ATPase and the Ca2+-ATPase is known to be a key
element in the transport mechanism. It works as a gating residue
at the ion binding pocket and furthermore directly binds and
moves the ions undergoing transport, being alternately exposed
toward the two sides of the membrane during the pump cycle.
Hence, in these P2-ATPase ion pumps M4 moves vertically
like a pump rod, allowing delivery to the exoplasm of Na+ or
Ca2+ bound at the M4 glutamate from the cytoplasmic side, or
delivery to the cytoplasm of K+/H+ bound at the same glutamate
from the exoplasmic side (Vilsen and Andersen, 1998; Olesen
et al., 2007; Toyoshima, 2009). It was therefore intriguing to
learn that a missense mutation replacing this isoleucine (I376
in human ATP8A2) with methionine had been identified as the
first (and so far only) disease-causing mutation in ATP8A2,
giving rise to CAMRQ (Onat et al., 2012). When expressed
in mammalian cell culture the equivalent mutation in bovine
ATP8A2, I364M, disrupted flipping of fluorescent NBD-labeled
PS and reduced ATPase activity to very low levels, although wild
type-like expression levels were retained. Analyses of the lipid
substrate concentration dependence of the overall and partial
reactions of the enzyme cycle in ATP8A2 mutants with various
replacements of this isoleucine led to the conclusion that during
the lipid flipping the PS head group passes near I364, and I364
is critical to the release of the lipid into the cytosolic leaflet
(Vestergaard et al., 2014).
To examine the exact role of I364, in the absence of a
crystal structure of a P4-ATPase, homology-based models of
ATP8A2 were built for E2P and E2 (the two states that interact
with the lipid substrate, cf. Figure 3B), starting from a multiple
sequence alignment and the high-resolution crystal structures
of the Ca2+-ATPase in these conformations. The models were
subsequently refined by molecular dynamics simulation, which
relaxed the original ATP8A2 homology model structures to
structures where a groove between the M1, M2, M4, and
M6 transmembrane helices had opened to a wider state, thus
suggesting that this region, now deviating significantly from
that of the P2-ATPase ion pumps, might be directly involved
in lipid transport by the P4-ATPases (Vestergaard et al.,
2014). Substantial amounts of water entered the groove during
the molecular dynamics refinement, gathering in two distinct
pockets placed in the exoplasmic and cytoplasmic ends of the
groove, separated by a cluster of hydrophobic residues that
included I364 (Figures 4A,B). This hydrated groove has a size
appropriate for accommodation of the PS head group and is
located rather peripherally in the protein, thus allowing the
hydrocarbon tail of the lipid to project out into the surrounding
membrane bilayer lipid during the flipping (Figures 4C,D),
exactly as proposed for the scramblase TMEM16 described above.
In the P4-ATPase, the phospholipid head group in the groove
would be solvated by the water in the groove, thereby aiding
the movement of the head group. An important feature of
the ATP8A2 E2P and E2 structural models is moreover that
I364 moves during the transition between these states, thereby
apparently functioning as a “hydrophobic gate” propelling the
water in the groove with the solvated phospholipid head
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group toward the cytoplasmic side against the concentration
gradient.
Mutational analysis further implicated adjacent hydrophobic
residues including I115 (of M2) as part of the gate (Vestergaard
et al., 2014). The polar residue N359 (of M4) appears to
be involved in the recognition of the lipid substrate entering
the groove from the exoplasmic side (Figures 4A,B, 5).
These findings suggest a plausible phospholipid translocation
mechanism that is both distinct from and related to the well-
characterized P2-ATPase ion transport mechanisms. In lipid
pumps as well as ion pumps, M4 plays a central role as the
pump rod generating the movement. In fact, the less wide
groove present between M1, M2, M4, and M6 in the Ca2+-
ATPase also seems to contain water and has been proposed to
be the pathway taken by Ca2+ migrating from the cytoplasmic
side to the Ca2+ occlusion pocket (Musgaard et al., 2012),
thus overlapping partially with the hydrophobic gate pathway
proposed for ATP8A2 (Vestergaard et al., 2014). In a recent
review (Montigny et al., 2016) it was furthermore pointed
out that the most conserved of the two Ca2+ binding sites
found in Ca2+-ATPases is the one involving the glutamate
in M4 corresponding to I364 of ATP8A2, denoted site II in
SERCA, implying that Ca2+-ATPases like PMCA and SPCA
that only transport one Ca2+ in each cycle do not possess a
site corresponding to site I of SERCA, and therefore do not
use residues in M5 and M8 for Ca2+ binding. Hence, the
hydrophobic gate pathway must be very similar to the transport
pathway used by the one-site Ca2+-ATPases and possibly also
other P-type ATPases pumping a single ion per cycle (Montigny
et al., 2016). As previously alluded to in discussing the relation
between P2- and P4-ATPases (Lenoir et al., 2007; Baldridge et al.,
2013), the Ca2+-ATPase E2 crystal structure shows the presence
of a phospholipid molecule approximately corresponding to
the cytoplasmic exit of the hydrophobic gate pathway (top of
Figure 5). In the P4-ATPases, this primordial phospholipid-
binding site might have evolved into a site playing a role in the
lipid transport.Worthmentioning in relation to the conservation
of the structure and basic mechanism between P2- and P4-
ATPases is also the proline adjacent to the isoleucine in the PISL
motif (Figure 2). This proline is conserved in all P-type ATPases,
and in ATP8A2 the P363A mutation abrogated expression of the
protein in HEK cells, suggesting that the local unwinding of the
M4 helix near PISL caused by the presence of the proline is crucial
to proper folding and processing of the protein (Vestergaard
et al., 2014).
Merge of Structural Models Resulting from ATP8A2
and Yeast Flippase Studies of the Lipid Transport
Pathway
The structural locations of the various proposed P4-ATPase
lipid translocation pathways are summarized in Figure 6:
the peripheral pathway associated with the hydrophobic gate
(between M1, M2, M4, and M6; Vestergaard et al., 2014);
the central pathway implying occlusion of the lipid between
M4, M5, M6, and M8 similar to the occlusion of ions in
the two-sites Ca2+-ATPases and the Na+,K+-ATPase; and the
non-canonical pathway between M1, M3, and M4 (Baldridge
and Graham, 2012, 2013). It is of note that in the structural
model of Vestergaard et al. (2014), the M4 residue L367,
which is equivalent to Y618 shown to be important for
lipid head group selectivity in yeast Dnf1p (Baldridge and
Graham, 2012, 2013), points toward the hydrophobic gate
pathway, being located one helix turn above I364 (Figure 5).
Likewise, the M2 residues A119 and E123 at positions equivalent
to yeast Dnf1 residues T254 and D258 shown to couple
with the M4 Y618 to confer lipid head group selectivity
(Baldridge et al., 2013), seem in the structural model of
Vestergaard et al. (2014) to be associated with the cytoplasmic
exit of the hydrophobic gate pathway (Figure 5). On the
other hand, N302, equivalent to the asparagine N550 also
pinpointed as critical for head group selectivity in the yeast
flippase studies (Baldridge and Graham, 2013), is too distant
FIGURE 5 | Proposed hydrophobic gate pathway in side view with
indication of residues that might play a role in the recognition and
translocation of the phospholipid. The E2 structural model of the ATP8A2
membrane domain (Vestergaard et al., 2014) is visualized with the cytoplasmic
side up. Selected residues, some of which are mentioned in the text, are
shown in licorice representation with carbons in orange for hydrophobic
residues and in yellow for polar/charged residues. Water molecules in the
groove are shown as cyan transparent spheres. I364 and I115 are key residues
in the hydrophobic gate. N359 is important for the affinity for the lipid substrate
(Vestergaard et al., 2014). Q95, Q96, A119, E123, N302, and L367 are located
at positions corresponding to the yeast Dnf1 flippase residues G230, A231,
T254, D258, N550, and Y618, which have been shown to be crucial to the
specific lipid selectivity of this flippase (Baldridge and Graham, 2012, 2013).
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FIGURE 6 | Overview of the locations of three proposed phospholipid transport pathways and possible location of CDC50. The refined membrane
domain of the E2 structural model of ATP8A2 (Vestergaard et al., 2014) is visualized as viewed from the cytoplasmic side. Helices M1–M2 are shown in purple,
M3–M4 in green, M5–M6 in brown, and M7–M10 in gray. Selected residues mentioned in the text are shown in licorice representation with carbons in orange for
hydrophobic residues and in yellow for polar/charged residues. Recent evidence suggests a location of the CDC50 protein corresponding to the non-canonical
peripheral pathway (Vestergaard et al., 2015).
from the hydrophobic gate pathway to be directly involved
(Figures 5, 6).
It is clear that in addition to the hydrophobic gate, residues on
its cytoplasmic side pointing toward the proposed translocation
pathway contribute to determining the affinity for the lipid
substrate. The yeast flippase studies have furthermore identified
two residues near the exoplasmic end of M1 that are important
for lipid substrate recognition (Baldridge and Graham, 2013). At
the equivalent positions of ATP8A2 are Q95 and Q96 shown in
Figure 5. These residues might be associated with the exoplasmic
entrance to the hydrophobic gate pathway. The separation of the
residues critical to lipid substrate recognition in two clusters, one
near the exoplasm and the other near the cytoplasm, observed in
the yeast flippase studies, led to the view that there are two gates,
an entry gate, and an exit gate (Baldridge and Graham, 2013).
In fact the studies of ATP8A2 indicate that there are residues
critical to the interaction with the lipid substrate all along the
hydrophobic gate pathway. It is, however, not clear why residues
near the cytoplasmic exit of the putative translocation pathway
should be as critical for the lipid substrate recognition as the
residues at the inlet. One possibility is that residues near the exit
form bonds (note in Figure 5 that K122 and E371 are very close,
probably forming a salt bridge) required to position the helices
correctly for entry and recognition of the lipid substrate at the
other end of the groove.
Role of the M5 Lysine
In light of the proposal of the hydrophobic gate pathway one
might wonder about the role of the more centrally placed critical
lysine K873 of transmembrane helix M5 discussed above. In
our refined models, K873 is situated on the opposite side of
M4 with respect to the hydrophobic cluster including I364 and
does not point into the suggested transport pathway (Figure 6).
K873 is closely surrounded by polar residues with which it
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may form hydrogen bonds, including N905 located at the
position corresponding to an ion binding asparagine/aspartate
of Ca2+-ATPase and Na+/K+-ATPase (Figure 2), and this part
of the models was most stable during refinement. K873 might
therefore acts as a stabilizer of the central part of the structure,
aiding the correct placement of the dynamic regions including
M4 and the hydrophobic gate.
Structural Location of the CDC50 Protein
The “dark horse” in the modeling studies, so far not taken
properly into consideration, is the CDC50 protein (the β-
subunit). Recently, screening of 141 point mutations of the
ATP8A2 catalytic subunit pinpointed six mutations that
indirectly affect the glycosylation of the CDC50 protein,
suggesting the possibility of a defect in the structural interaction
between the two subunits of the complex (Vestergaard
et al., 2015). Interestingly, in our structural model four of
the six residues implicated are situated above each other
almost along a line at the periphery of the ATP8A2 protein,
pointing toward the putative location of the non-canonical
pathway, between M1, M3, and M4 (Figure 6). Hence, one
or both transmembrane helices of CDC50 might actually
be located corresponding to the non-canonical pathway,
which would place the CDC50 exoplasmic domain in
close proximity to the putative exoplasmic entrance of the
hydrophobic gate pathway, thereby enabling CDC50 to
directly promote substrate binding in the hydrophobic gate
pathway.
CONCLUSIONS AND FUTURE
PERSPECTIVES
Cell-based and biochemical studies from a number of research
groups have convincingly shown that P4-ATPases actively flip
phospholipids from the exoplasmic to the cytoplasmic leaflet
of the plasma membrane and intracellular membranes. Like
yeast P4-ATPases, some members of the mammalian P4-ATPase
family actively transport the PS and PE to generate and maintain
lipid asymmetry, whereas other members appear to be specific
for PC. Cell culture and animal studies in which specific
P4-ATPases are overexpressed or knocked down support the
importance of these mammalian P4-ATPases in generating and
maintaining lipid asymmetry for such key cellular processes
as vesicle budding and trafficking, cell migration, neurite
extension and cell survival. Although, significant progress has
been made, a number of questions and areas of investigation
remain. The distribution of P4-ATPases in native tissues and
cells and their role in various biochemical pathways need to
be studied in more detail. The substrate specificity of several
mammalian P4-ATPases including ATP9A and ATP9B remain
to be determined. Whether these proteins require an auxiliary
protein to complete the flippase complex also remains to be
determined. The mechanisms for regulation and subcellular
targeting of mammalian P4-ATPases have yet to be examined
in detail. We still know relatively little about the individual
CDC50 proteins and their role in lipid flippase activity.Molecular
modeling together with site-directed mutagenesis has provided
important insight into how P4-ATPasesmay recognize and pump
specific phospholipid substrates across membranes. Although,
the lipid substrates of P4-ATPases are “giant” in comparison with
the ions translocated by ion pumps, similarities between lipid
and ion pumps of P-type greatly outnumber their differences.
Not only are the mechanisms for ATP hydrolysis the same,
but even the handling of the lipid substrate has much in
common with the pumping of ions, and the suggested transport
pathways of P-type lipid pumps and ion pumps appear to overlap
to some extent. The hydrophobic gate pathway hypothesis
should be validated by additional mutational studies, with the
aim of identifying the determinants of the specific substrate
selectivity of the P4-ATPases. For example, is there a “selectivity
gate” at the exoplasmic entrance of the pathway, perhaps
involving the CDC50 protein? A full understanding of the
mechanism will require determination of the structure of a
P4-ATPase with its bound lipid substrate. The highly purified
ATP8A2 preparation recently developed seems optimal for such
studies.
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